RET and medullary thyroid gland carcinoma: MTC is associated with activators of the RET proto-oncogene, which codes for a membrane receptor of the tyrosine-kinase type of 150-170 kD highly expressed in normal and tumor cells derived from the neural crest, including parafollicular thyroid cells.